Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Is COVID-19, a bacterium, or a virus?

NICED Influenza Project Recruitment For Life Science | Applications Invited

Disease tolerance mechanism in sepsis patients identified!

Is COVID-19, a bacterium, or a virus?
  • BiotechToday
  • World

Is COVID-19, a bacterium, or a virus?

bioxone October 18, 2020October 18, 2020

Salapu Chandralekha, Amity University Kolkata

What secret did the Italian doctors uncover to prove that the COVID-19 is a bacterium, not a virus as advocated by the WHO guidelines? Italy was one of the European Nation’s which bore the brunt of COVID-19 pandemic accounting for over for 7.2% of deaths recorded across the Globe with hospitals running out of infrastructure and the country’s administration losing direction in dealing with the situation. 

The situation was such that no treatment protocol could put a brake on the deaths and while one section of the Doctors was busy attending to the patients, there was another group of scientists/ researchers busy trying to unravel the myth of whether or not COVID is a virus. It is said that anti-inflammatory drugs and antibiotics can cure COVID-19 but at the same time the Doctor’s world over believe that there is no role of antibiotics in treating coronavirus but these are administered to resist secondary or collateral bacterial infections. The clinical management aims at improving the immunity factor as a major tool in fighting COVID-19.

Italian Doctors observed that thrombosis or blood clot is the cause and not pneumonia. The contemporary world belief says that thrombosis or coagulation of blood cells or blood clots is a frequent complication found in COVID-19 patients but simultaneously, the deaths of COVID patients’ due to this is accounting for less than 20%. However, there is no scientific evidence that confirms thrombosis as the major cause of COVID-19 death.

As also foreseen by the Italian Doctors that the COVID patients do not require ventilators and intensive care units for treatment were slashed by the world contemporaries saying that, “Most deaths are due to interstitial pneumonia and respiratory failures and to say that the patients should not be incubated is completely outrageous”. The medical fraternity across Nations have different notions on the exact treatment regime for curing COVID – 19 patients and different nations followed different protocols. While the world ponders over the myth of whether Corona is a virus or bacterium, let’s stay safe hoping for an appropriate vaccine.

Also read: Are COVID-19 patients diagnosed with Down Syndrome prone to severe diseases?

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged Anti-inflammatory drugs blood-clot clinical protocol coagulation collateral bacterial infection contemporary COVID-19 intensive care units pneumonia thrombosis ventilators

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Disease tolerance mechanism in sepsis patients identified!

bioxone October 18, 2020

Prama Ghosh, Amity University Kolkata Sepsis, a complication caused by dysregulation of the immune system causes around 11 million deaths every year in the world. Treatment includes antibiotics and organ support measures, but it fails many times due to unsuccessful attempts at modulating the immune response. Surviving the condition requires activation of resistance mechanisms which […]

Disease tolerance

Related Post

  • BiotechToday
  • World

Studying p38-MAPK – A signaling pathway in mice embryos

BioTech Today July 17, 2021July 17, 2021

Agrima Bhatt, Rajasthan University In previous studies, p38-MAPK was identified as a regulator for blastocyst ICM fate in the mouse embryo. Today, scientists are trying to find out the functional role of the DDX21 protein. For the understanding of this complex pathway, let’s first deep dive into the embryo and its development stages. Fusion of […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

HELLO- A method based on DNN architecture

bioxone August 18, 2021August 18, 2021

Madhavi Bhatia, National Pharmaceutical Education and Research, Guwahati Variant calling is the process by which we can identify variants in the sequence data provided. Variant calling has a major application in modern bioinformatics. It helps in discovering the underlying traits of Mendelian diseases, in understanding the individual’s susceptibility to cancer, and also to study genetic […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Zolgensma: World’s most expensive life-saving drug approved

bioxone March 11, 2021March 11, 2021

Husna, Amity University Kolkata United Kingdom’s National Health Service (NHS) has approved the most expensive drug of ₹18 crores (£1.79 million) per dose to cure a rare genetic disorder. The drug Zolgensma, manufactured by Novartis Gene Therapies can treat Spinal Muscular Atrophy (SMA) which is a rare and often fatal genetic disease that causes paralysis […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy

Protected by Malware Removal